BNP Paribas Streamlines Asset‑Management and Boosts Chinese Biopharma ExposureBNP Paribas consolidates five Axa funds into a single platform, slashing costs and boosting liquidity while inching its biopharma stake for growth.BNP PARIBAS Financials Banks AI generated Daniel Carter 26/09/2026, 06:48 4 minutes to read